Dendritic cells (DCs) are powerful antigen-presenting cells with a unique ability to induce primary T cell responses. The availability of immature human DCs is critical for the study of antigen processing and presentation, and for understanding the mechanisms of inducing immunity and tolerance. Functional analysis of human DC subsets was significantly facilitated by development of an in vitro system for DC differentiation from CD34+ hematopoietic stem cells and monocytes. However, obtaining large numbers of human DC progenitors is still a laborious process and poses potential risks for donors. Human embryonic stem (hES) cells represent a unique population of cells capable of self-renewal and differentiation, and directed hematopoietic differentiation of hES cells reproduces many aspects of embryonic hematopoiesis. Therefore, hES cells can be used as a unique source of hematopoietic and DC precursors to address the essential questions of DC development. In addition, since ES cells can be expanded without limit, they can be seen as an alternative scalable source of cells for DC vaccines or DC-mediated induction of immune tolerance. We recently developed a method for the efficient differentiation of hES cells into hematopoietic cells and DCs utilizing hES cell/OP9 coculture. The overall goal of this proposal is to apply the described model to identify the population of myeloid DC precursors, which can be expanded through activation of the Wnt/?-catenin pathway. In the first specific aim, we will characterize the hierarchy of hES cell-derived myeloid DC precursors. In the second specific aim we will evaluate the effect of ?-catenin on the proliferation and differentiation of hES cell-derived myeloid DC progenitors at different stages of maturation using a tamoxifen-inducible promoter system to conditionally express ?-catenin. Eventually, these studies will assist with developing protocols for the production of DCs from hES cells in large quantities and with desired functional characteristics. In addition, accomplishment of the above-listed aims will provide new insights into cellular pathways of DC development and on how the Wnt/?-catenin pathway influences the survival and proliferation of hES cell-derived myeloid DC progenitors. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL085223-01A1
Application #
7255341
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Mondoro, Traci
Project Start
2007-05-01
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
1
Fiscal Year
2007
Total Cost
$179,990
Indirect Cost
Name
University of Wisconsin Madison
Department
Veterinary Sciences
Type
Other Domestic Higher Education
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Choi, Kyung-Dal; Vodyanik, Maxim; Slukvin, Igor I (2011) Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc 6:296-313
Choi, Kyung-Dal; Yu, Junying; Smuga-Otto, Kim et al. (2009) Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559-67
Choi, Kyung-Dal; Vodyanik, Maxim A; Slukvin, Igor I (2009) Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J Clin Invest 119:2818-29